EUROFINS SCIENT. overview

Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached i (including the issuer ID allocated by the CSSF) EUROFINS SCIENTIFIC SE – E1013 Identity of the notifier (if another...

Regulatory News: Eurofins (Paris:ERF): Eurofins Scientific (EUFI.PA, rated Baa3 by Moody’s and BBB- by Fitch, “ Eurofins ”), a global leader in bioanalytical testing, announces today the results of the tender offer (the “ Tender Offer ”) in respect of its €400m 3.250% hybrid bond (ISIN: XS1716945586) issued on 13 November 2017 with a first call date on 13 November 2025 (the “ 2025 Hybrid Bond ”). At the expiration deadline of the Tender Offer (2 April 2025, 5pm CEST), Eurofins...

Regulatory News: Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing, with a rapidly developing presence in highly specialised and molecular clinical diagnostics testing and in-vitro diagnostics products, announces the successful closing of the acquisition of SYNLAB’s clinical diagnostics operations in Spain and the transfer of operations to Eurofins, which took place on 31 March 2025. SYNLAB’s clinical diagnostics operations in Spain comprise clinical...

Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS 529900JEHFM47DYY3S57 24/03/2025 FR0014000MR3 112,452 51.0468 XPAR EUROFINS 529900JEHFM47DYY3S57 24/03/2025 FR0014000MR3 33,548 50.9670 CEUX EUROFINS 529900JEHFM47DYY3S57 24/03/2025 FR0014000MR3 2,000 50.9882 TQEX EUROFINS...

Regulatory News: Eurofins (Paris:ERF): Eurofins Scientific (EUFI.PA, rated Baa3 by Moody’s and BBB- by Fitch), a global leader in bioanalytical testing, announces that it has successfully raised €400m in its latest Euro hybrid bond public issuance. The transaction was well received and more than 3x times over-subscribed. This new series of bonds has no specified maturity date and is accounted for as 100% equity according to international financial reporting standards (IFRS) and 50% equity...

Regulatory News: Eurofins Scientific (EUFI.PA, rated Baa3 by Moody’s and BBB- by Fitch) (Paris:ERF), a global leader in bioanalytical testing, announces today: its intention to issue a new Euro-denominated hybrid bond for an amount of €400m (“ New Hybrid Bond ”) and the launch of tender offer (the “ Tender Offer ”) to repurchase its €400m 3.250% hybrid bond (ISIN: XS1716945586) issued on 13 November 2017 with a first call date of 13 November 2025 (“ 2025 Hybrid Bond ”) The...

Regulatory News: This replaces the announcement made at 12:45 p.m. ET on March 24, 2025. The links have been updated. Eurofins Publishes the Agenda for Its Upcoming Annual General Meeting and Extraordinary General Meeting of Shareholders While Reaffirming Its Commitment to a Sustainably Strong Balance Sheet Eurofins (Paris:ERF): Eurofins Scientific SE (the “Company”) (EUFI.PA) announces the publication of the agenda for its upcoming Annual General Meeting (AGM) and Extraordinary General...

Regulatory News: Eurofins (Paris:ERF): Disclaimer : this document is a non-binding English translation of the convening notice of the shareholders to the Annual Ordinary General Meeting and an Extraordinary General Meeting to be held on Thursday 24 April 2025 – the French version of the convening notice (“ avis de convocation des actionnaires à l’assemblée générale ordinaire annuelle et une assemblée générale extraordinaire de la Société valant avis d’information des...